Patents by Inventor Chenguo FENG

Chenguo FENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11325937
    Abstract: The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: May 10, 2022
    Assignee: SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED
    Inventors: Guoqiang Lin, Jiange Zhang, Ping Tian, Chenguo Feng, Changsen Zhan, Junjie Zhou
  • Publication number: 20210115082
    Abstract: The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.
    Type: Application
    Filed: May 7, 2019
    Publication date: April 22, 2021
    Inventors: Guoqiang LIN, Jiange ZHANG, Ping TIAN, Chenguo FENG, Changsen ZHAN, Junjie ZHOU